
NaturalVue Multifocal wins The Contact Lens Award 2024 with the Positive Impact Team.
November 27, 2024
LONDON – Visioneering Technologies, Inc. was presented with The Contact Lens Award of 2024 by The Optician Awards in the United Kingdom on November 22. NaturalVue (etafilcon A) Multifocal 1 Day Contact Lenses, in partnership with authorized distributor Positive Impact, has won The Contact Lens Award at the prestigious Optician Awards. The Optician Awards celebrates excellence within the U.K. optical industry. With a legacy spanning over 30 years, these awards are among the most esteemed recognitions in British optics.
The Contact Lens Award honors products and companies that have made a significant impact in the contact lens market over the past year. Judged by a panel of U.K.-based contact lens specialists, this category evaluates each nominee based on innovation, contribution to market growth, and success in real-world practices.
The win recognizes the unique role that NaturalVue Multifocal lenses have played in advancing contact lens technology, along with VTI’s commitment to supporting eye care professionals and providing products that exceed customer expectations. The release of the Year 1 results from the three-year PROTECT (PROgressive Myopia Treatment Evaluation for NaturalVue Multifocal Contact Lens) study was instrumental in this nomination, showcasing VTI’s commitment to myopia management and improving patients’ quality of life.
Dr. Juan Carlos Aragón, CEO and Executive Director of VTI, noted: “A special thanks to Positive Impact, who put together an impressive and comprehensive submission for the award that among the highlights from our PROTECT study also included valuable feedback from NaturalVue fitters and patient experiences with the lenses. We are deeply honored to receive this coveted award and thank our partners for being part of our journey to bring innovative vision solutions to life!”
The PROTECT study, a three-year, randomized, double-masked, controlled clinical trial, evaluates the safety and efficacy of NaturalVue Multifocal lenses for managing myopia progression in children.
